Kinney Horn
Förmögenhet: 711 250 $ per 2026-07-31
Förmögenhet: 711 250 $ per 2026-07-31
Kinney Horn is currently Chief Business Officer at Immunome, Inc. since 2024.
Formerly, Mr. Horn was Chief Business Officer at Olema Pharmaceuticals, Inc. from 2020 to 2023 and Director-Business Development at Genentech, Inc. from 2003 to 2019.
Education includes graduate studies at Georgetown University and undergraduate studies at the University of Mary Washington.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
IMMUNOME, INC. 0,03 % | 2026-08-04 | 31 250 ( 0,03 % ) | 711 250 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| IMMUNOME, INC. | Företagsledare/Principal | 2024-02-01 |
| Företag | Position | Slut |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Företagsledare/Principal | 2023-10-01 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | 2019-04-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Immunome, Inc.
Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mary Washington
University of Mary Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån